A Drug-Target Network-Based Approach to Evaluate the Efficacy of Medicinal Plants for Type II Diabetes Mellitus
Authors:
Open Access
- 10 October 2013
- journal article
- research article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-7
Abstract
The use of plants as natural medicines in the treatment of type II diabetes mellitus (T2DM) has long been of special interest. In this work, we developed a docking score-weighted prediction model based on drug-target network to evaluate the efficacy of medicinal plants for T2DM. High throughput virtual screening from chemical library of natural products was adopted to calculate the binding affinity between natural products contained in medicinal plants and 33 T2DM-related proteins. The drug-target network was constructed according to the strength of the binding affinity if the molecular docking score satisfied the threshold. By linking the medicinal plant with T2DM through drug-target network, the model can predict the efficacy of natural products and medicinal plant for T2DM. Eighteen thousand nine hundred ninety-nine natural products and 1669 medicinal plants were predicted to be potentially bioactive.Keywords
Funding Information
- National Key Special Project of Science and Technology for Innovation Drugs (2012ZX09501001-004, 2013ZX09402202)
This publication has 58 references indexed in Scilit:
- Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trialJournal of Translational Medicine, 2013
- Use of Natural Products as Chemical Library for Drug Discovery and Network PharmacologyPLOS ONE, 2013
- Platelet Aggregation Pathway Network-Based Approach for Evaluating Compounds EfficacyEvidence-Based Complementary and Alternative Medicine, 2013
- Antihyperglycemic effect of Hypericum perforatum ethyl acetate extract on streptozotocin–induced diabetic ratsAsian Pacific Journal of Tropical Biomedicine, 2011
- DrugBank 3.0: a comprehensive resource for 'Omics' research on drugsNucleic Acids Research, 2010
- Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini reviewBritish Journal of Nutrition, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Network‐based global inference of human disease genesMolecular Systems Biology, 2008
- Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studiesThe Lancet, 2008
- Network pharmacologyNature Biotechnology, 2007